Functional Fas ligand expression in thyrocytes from patients with graves' disease

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 8, 1999, Pages 2896-2902

  Hiromatsu, Yuji ^a   Hoshino, Tomoaki ^a   Yagita, Hideo ^b   Koga, Mari ^a   Sakisaka, Shotaro ^a   Honda, Junnichi ^a   Yang, Damu ^a   Kayagaki, Nobuhiko ^b   Okumura, K O ^b   Nonaka, Kyohei ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN; GAMMA INTERFERON; LIGAND; MATRIX METALLOPROTEINASE INHIBITOR; PROTEIN BCL 2; RECEPTOR ANTIBODY; THYROTROPIN RECEPTOR;

ADENOMA; ADULT; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; THYROID FUNCTION; THYROID HYPERPLASIA;

EID: 0033345444     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.8.5682     Document Type: Article

References (30)

1. The Fas death factor
2. Apoptosis in the pathogenesis and treatment of disease
3. Fas and Fas ligand: Ipr and gld mutations
4. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
5. Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells-a mechanism of immune evasion? Nat Med
6. Autoimmune thyroiditis
7. Apoptosis in thyroid diseases: A histochemical study
8. Thyroid-stimulating hormone-inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro
9. Immunohistochemical detection of apoptosis in autoimmune thyroid disorder
10. Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis
11. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
12. An examination of Fas ligand expression on thyrocytes
13. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy
14. Metalloproteinase-mediated release of human Fas ligand
15. Possible involvement of Fas-mediated apoptosis in eye muscle tissue from patients with thyroid-associated ophthalmopathy. Thyroid
16. Human histocompatibility leukocyte antigen-DR and heat shock protein-70 expression in eye muscle tissue in thyroid-associated ophthalmopathy
17. Functional differences between hepatocytes and biliary epithelial cells in handling polymeric immunoglobulin A2 in humans, rats, and guinea pigs
18. Localization and clinical significance of thyrotropin receptor mRNA expression in orbital fat and eye muscle tissues from patients with thyroid-associated ophthalmopathy
19. Fas ligand mediates activation-induced cell death in human T lymphocytes
20. Hoshino T, Winkler-Pickett RT, Mason AT, Ortaldo JR, Young HA. IL-13 production by NK cells: IL-13-producing NK and T ceils are present in vivo in the absence of IFN-γ
21. Fas ligand-induced apoptosis as a mechanism of immune privilege
22. A role for CD95 ligand in preventing graft rejection
23. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis
24. Constitutive expression of FasL and thyrocytes
25. Constitutive expression of FasL and thyrocytes
26. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
27. Bcl-2 blocks degranulation but not Fas-based cell-mediated cytotoxicity
28. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice
29. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema
30. Fas (APO-1, CD95)-mediated apoptosis is thyroid cells is regulated by a labile protein inhibitor